Landing Med Overview

  • Year Founded
  • 2000

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Series D

  • Latest Deal Amount
  • $49.9M

  • Investors
  • 7

Landing Med General Information

Description

Developer and manufacturer of medical screening devices intended to detect cancer cells. The company specializes in medical screening devices that utilizes big data and artificial intelligence to group, analyze and diagnose potential cancer cells, enabling medical institutions to achieve quicker diagnosis of cancer and proceed with treatment.

Contact Information

Website
www.landing-med.com
Formerly Known As
Wuhan Landing Medical High Technology Co., Ltd.
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Building B7, Medical Instrument Park
  • No. 818 Gaoxin Avenue, Donghu New Technology Development Zone
  • Wuhan, Hubei 430000
  • China
+86 400
Primary Industry
Diagnostic Equipment
Vertical(s)
Big Data, Manufacturing, Artificial Intelligence & Machine Learning, Life Sciences, Oncology
Corporate Office
  • Building B7, Medical Instrument Park
  • No. 818 Gaoxin Avenue, Donghu New Technology Development Zone
  • Wuhan, Hubei 430000
  • China
+86 400

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Landing Med Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Later Stage VC (Series D) 10-Nov-2021 $49.9M Completed Generating Revenue
5. Later Stage VC (Series C) 01-Jan-2020 Completed Generating Revenue
4. Later Stage VC (Series B) 24-Oct-2018 Completed Generating Revenue
3. Later Stage VC (Series A) 27-May-2017 Completed Generating Revenue
2. Later Stage VC 01-Jan-2016 Completed Generating Revenue
1. Later Stage VC 01-Sep-2014 Completed Generating Revenue
To view Landing Med’s complete valuation and funding history, request access »

Landing Med Patents

  • 7

    Total Documents Applications and Grants

  • Total Patents Families

  • 4

    Granted

  • Pending

  • Expiring in next 12 mo

Landing Med Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2021093108-A1 Cellular miniature microscopic image acquisition device and image recognition method Inactive 14-Nov-2019
US-11586028-B2 Mobile phone-based miniature microscopic image acquisition device and image stitching and recognition methods Active 14-Nov-2019
US-20220269060-A1 Mobile phone-based miniature microscopic image acquisition device and image stitching and recognition methods Active 14-Nov-2019
WO-2021093109-A1 Mobile phone-based miniature microscopic image acquisition device, image splicing method, and image recognition method Inactive 14-Nov-2019
US-11817215-B2 Artificial intelligence cloud diagnosis platform Active 11-Oct-2019 G16H50/20
To view Landing Med’s complete patent history, request access »

Landing Med Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
Alibaba Health Information Technology Holding Company Minority
Sinopharm CICC Venture Capital Minority
Bank of China Group Investment PE/Buyout Minority
China Merchants Venture Capital Corporate Venture Capital Minority
Shenzhen Sangel Venture Capital Venture Capital Minority
You’re viewing 5 of 7 investors. Get the full list »

Ready to get started?

Request a free trial

Landing Med FAQs

  • When was Landing Med founded?

    Landing Med was founded in 2000.

  • Where is Landing Med headquartered?

    Landing Med is headquartered in Wuhan, China.

  • What industry is Landing Med in?

    Landing Med’s primary industry is Diagnostic Equipment.

  • Is Landing Med a private or public company?

    Landing Med is a Private company.

  • What is Landing Med’s current revenue?

    The current revenue for Landing Med is .

  • How much funding has Landing Med raised over time?

    Landing Med has raised $49.9M.

  • Who are Landing Med’s investors?

    Alibaba Health Information Technology, Sinopharm CICC, Bank of China Group Investment, China Merchants Venture Capital, and Shenzhen Sangel Venture Capital are 5 of 7 investors who have invested in Landing Med.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process